Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review
Journal of Neuroimaging · 2025-01 · 35 (1)
DOI: 10.1111/jon.13251 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Neuroimaging, online erschienen am 09.12.2024. Verfasst von Francesca M Cozzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Brain Tumour Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Camb…. Hauptthemen laut MEDLINE: Glioblastoma, Diffusion Tensor Imaging, Brain Neoplasms, Disease Progression. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amma Kyei-Mensah Medical Scholarship, Stamps Scholarship, Cancer Research UK Clinical Research Training Fellowship.
Abstract (Originalsprache)
Background and purpose Despite multimodal treatment of glioblastoma (GBM), recurrence beyond the initial tumor volume is inevitable. Moreover, conventional MRI has shortcomings that hinder the early detection of occult white matter tract infiltration by tumor, but diffusion tensor imaging (DTI) is a sensitive probe for assessing microstructural changes, facilitating the identification of progression before standard imaging. This sensitivity makes DTI a valuable tool for predicting recurrence. A systematic review was therefore conducted to investigate how DTI, in comparison to conventional MRI, can be used for predicting GBM progression.
Methods
We queried three databases (PubMed, Web of Science, and Scopus) using the search terms: (diffusion tensor imaging OR DTI) AND (glioblastoma OR GBM) AND (recurrence OR progression). For included studies, data pertaining to the study type, number of GBM recurrence patients, treatment type(s), and DTI‐related metrics of recurrence were extracted.
Results
In all, 16 studies were included, from which there were 394 patients in total. Six studies reported decreased fractional anisotropy in recurrence regions, and 2 studies described the utility of connectomics/tractography for predicting tumor migratory pathways to a site of recurrence. Three studies reported evidence of tumor progression using DTI before recurrence was visible on conventional imaging.
Conclusions
These findings suggest that DTI metrics may be useful for guiding surgical and radiotherapy planning for GBM patients, and for informing long‐term surveillance. Understanding the current state of the literature pertaining to these metrics’ trends is crucial, particularly as DTI is increasingly used as a treatment‐guiding imaging modality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cambridge Brain Tumour Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
ORCID-Profile: Francesca M Cozzi
Förderung
- Amma Kyei-Mensah Medical Scholarship
- Stamps Scholarship
- Cancer Research UK Clinical Research Training Fellowship
- CRUK Cambridge Centre
- National Institute for Health and Care Research
- Career Development Fellowship
- NIHR HealthTech Research Centre in Brain Injury
- NIHR Cambridge Biomedical Research Centre
Zitieren
APA
Cozzi, F. M., Mayrand, R. C., Wan, Y., & Price, S. J. (2025). Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review. Journal of Neuroimaging, 35(1). https://doi.org/10.1111/jon.13251
Vancouver
Cozzi FM, Mayrand RC, Wan Y, Price SJ. Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review. Journal of Neuroimaging. 2025;35(1). doi:10.1111/jon.13251
BibTeX
@article{Cozzi2025,
author = {Cozzi, Francesca M and Mayrand, Roxanne C and Wan, Yizhou and Price, Stephen J},
title = {Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review},
journal = {Journal of Neuroimaging},
year = {2025},
volume = {35},
number = {1},
doi = {10.1111/jon.13251}
}
EUVIMED